metricas

Radiología

Sugerencias
Radiología La importancia de la TCMD en la evaluación de los factores de riesgo antes del ...
Información de la revista
Vol. 66. Núm. 4.
Páginas 305-400 (Julio - Agosto 2024)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1974
Vol. 66. Núm. 4.
Páginas 305-400 (Julio - Agosto 2024)
Actualización

La importancia de la TCMD en la evaluación de los factores de riesgo antes del procedimiento TAVI y de sus complicaciones

The importance of MDCT in the evaluation of risk factors before the TAVI procedure and its complications after implantation
Visitas
1974
A. Aranaz Murilloa,
Autor para correspondencia
aaranaz@salud.aragon.es

Autor para correspondencia.
, M.C. Ferrer Graciab, I. Dieste Grañenac, M.E. Guillén Subirána
a Servicio de Radiología, Hospital Universitario Miguel Servet, Zaragoza, España
b Servicio de Cardiología, Hospital Universitario Miguel Servet, Zaragoza, España
c Servicio de Radiología, Hospital Royo Villanova, Zaragoza, España
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Resumen

El implante valvular aórtico transcatéter (TAVI) es la alternativa al reemplazo valvular quirúrgico. En las últimas guías se han ampliado sus indicaciones. La TC multidetector (TCMD) es fundamental, tanto en la selección de pacientes como para valorar las complicaciones. Las complicaciones vasculares son frecuentes, por lo que es importante analizar la anatomía de los vasos antes del procedimiento. En cuanto a las roturas anulares y perforaciones ventriculares, tanto el volumen y la distribución del calcio como el diámetro ventricular juegan un papel importante. Finalmente, la migración valvular es una complicación rara que puede ocurrir tanto durante como después del TAVI. La planificación adecuada del procedimiento mediante la TCMD reduce el riesgo de complicaciones y da seguridad al intervencionista antes y durante el procedimiento.

Palabras clave:
TAVI
Tomografía computarizada
Factores de riesgo
Complicaciones
Diagnóstico
Abstract

Transcatheter aortic valve implantation (TAVI) is the alternative to surgical valve replacement, expanding its indications in the latest guidelines. Multidetector CT (MDCT) is essential in patient selection and detection of complications. Vascular complications are frequent, so it is important to analyze the anatomy of the vessels before the procedure. Regarding annular ruptures and ventricular perforations, the volume and distribution of calcium and the ventricular diameter play an important role. Finally, valve migration is a rare complication that can occur both during and after TAVI. Proper planning of the MDCT procedure reduces the risk of complications and gives the interventional cardiologist security both before and during the procedure.

Keywords:
TAVI
Computed tomography
Risk factors
Complications
Diagnosis

Artículo

Opciones para acceder a los textos completos de la publicación Radiología
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
M. Zimarino, R. Waksman, I. Amat-Santos, C. Tamburino.
Aortic Valve Transcatheter Intervention. Complications and Solutions..
Wiley-Blackwell, (2021), pp. 288
[2]
A.P. Durko, R.L. Osnabrugge, N.M. Van Mieghem, M. Milojevic, D. Mylotte, V.T. Nkomo, et al.
Annual number of candidates for transcatheter aortic valve implantation per country: Current estimates and future projections.
Eur Heart J, 39 (2018), pp. 2635-2642
[3]
C.M. Otto, R.A. Nishimura, R.O. Bonow, B.A. Carabello, J.P. rwin, F. Gentile, et al.
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, 143 (2021), pp. 72-227
[4]
A. Vahanian, F. Beyersdorf, F. Praz, M. Milojevic, S. Baldus, J. Bauersachs, et al.
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
Rev Esp Cardiol (Engl Ed), 75 (2022), pp. 524
[5]
T. Pawade, T. Sheth, E. Guzzetti, M.R. Dweck, M.A. Clavel.
Why and How to Measure Aortic Valve Calcification in Patients With Aortic Stenosis.
JACC Cardiovasc Imaging, 12 (2019), pp. 1835-1848
[6]
C. Tamburino, D. Capodanno, A. Ramondo, A.S. Petronio, F. Ettori, G. Santoro, et al.
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.
Circulation, 123 (2011), pp. 299-308
[7]
P. Généreux, N. Piazza, M.C. Alu, T. Nazif, R.T. Hahn, P. Pibarot, et al.
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.
J Am Coll Cardiol, 77 (2021), pp. 2717-2746
[8]
M.E. Guillén Subirán, L.H. Ros Mendoza, E. Angulo Herviás, D. Yagüe Romeo, M.E. Núñez Motilva.
Multidetector computed tomography evaluation of candidates for transcatheter aortic valve implantation.
Radiologia., 60 (2018), pp. 85-89
[9]
M. Guillén Subirán.
La Tomografía Computarizada Multidetector (TCMD) en el programa de implantación percutánea de válvula aórtica (TAVI) en Aragón. Universidad de Zaragoza, (2015),
[10]
S.U. Khan, A.N. Lone, M.A. Saleem, E. Kaluski.
Transcatheter vs surgical aortic-valve replacement in low- to intermediate-surgical-risk candidates: A meta-analysis and systematic review.
Clin Cardiol, 40 (2017), pp. 974-981
[11]
P. Blanke, J.R. Weir-McCall, S. Achenbach, V. Delgado, J. Hausleiter, H. Jilaihawi, et al.
Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Consensus Document of the Society of Cardiovascular Computed Tomography.
JACC Cardiovasc Imaging, 12 (2019), pp. 1-24
[12]
M. Naik, C. McNamara, R.J. Jabbour, D. Gopalan, G.W. Mikhail, S. Mirsadraee, et al.
Imaging of transcatheter aortic valve replacement complications.
Clin Radiol, 76 (2021), pp. 27-37
[13]
M.J. Mack, M.B. Leon, V.H. Thourani, R. Makkar, S.K. Kodali, M. Russo, et al.
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
N Engl J Med, 380 (2019), pp. 1695-1705
[14]
N.C. Hansson, E.L. Grove, H.R. Andersen, J. Leipsic, O.N. Mathiassen, J.M. Jensen, et al.
Transcatheter Aortic Valve Thrombosis: Incidence Predisposing Factors, and Clinical Implications.
J Am Coll Cardiol, 68 (2016), pp. 2059-2069
[15]
L. Testa, A. Latib.
Assessing the risk of leaflet motion abnormality following transcatheter aortic valve implantation.
Interv Cardiol Rev, 13 (2018), pp. 37-39
[16]
L. Tang, J.R. Lesser, L.M. Schneider, M.R. Burns, M. Gössl, R. Garberich, et al.
Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Implantation.
Am J Cardiol, 123 (2019), pp. 658-666
[17]
M. Mokin, R. Zivadinov, M.G. Dwyer, R.M. Lazar, L.N. Hopkins, A.H. Siddiqui.
Transcatheter aortic valve replacement: Perioperative stroke and beyond.
Expert Rev Neurother, 17 (2017), pp. 327-334
[18]
A. Muralidharan, K. Thiagarajan, R. Van Ham, T.G. Gleason, S. Mulukutla, J.T. Schindler, et al.
Meta-Analysis of Perioperative Stroke and Mortality in Transcatheter Aortic Valve Implantation.
Am J Cardiol, 118 (2016), pp. 1031-1045
[19]
H.B. Ribeiro, L. Nombela-Franco, M. Urena, M. Mok, S. Pasian, D. Doyle, et al.
Coronary obstruction following transcatheter aortic valve implantation: A systematic review.
JACC Cardiovasc Interv, 6 (2013), pp. 452-461
[20]
H.B. Ribeiro, J. Rodés-Cabau, P. Blanke, J. Leipsic, J. Kwan Park, V. Bapat, et al.
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry.
Eur Heart J, 39 (2018), pp. 687-695
[21]
H.B. Ribeiro, J.G. Webb, R.R. Makkar, M.G. Cohen, S.R. Kapadia, S. Kodali, et al.
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry.
J Am Coll Cardiol, 62 (2013), pp. 1552-1562
[22]
M. Pasic, A. Unbehaun, S. Buz, T. Drews, R. Hetzer.
Annular rupture during transcatheter aortic valve replacement: Classification, pathophysiology, diagnostics, treatment approaches, and prevention.
JACC Cardiovasc Interv, 8 (2015), pp. 1-9
[23]
I. Dieste Grañena, M.E. Guillén Subirán, M.C. Ferrer Gracia, E. Angulo Hervías.
Rotura de raíz aórtica con formación de shunt intracardíaco secundaria a implante valvular aórtico transcatéter.
Radiologia, 61 (2019), pp. 341-344
[24]
M. Pasic, A. Unbehaun, S. Dreysse, S. Buz, T. Drews, M. Kukucka, et al.
Rupture of the device landing zone during transcatheter aortic valve implantation: A life-threatening but treatable complication.
Circ Cardiovasc Interv, 5 (2012), pp. 424-432
[25]
M. Barbanti, T.H. Yang, J. Rodès Cabau, C. Tamburino, D.A. Wood, H. Jilaihawi, et al.
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement.
Circulation, 128 (2013), pp. 244-253
[26]
N.C. Hansson, B.L. Nørgaard, M. Barbanti, N.E. Nielsen, T.H. Yang, C. Tamburino, et al.
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement.
J Cardiovasc Comput Tomogr, 9 (2015), pp. 382-392
[27]
T. Owais, M. El Garhy, J. Fuchs, K. Disha, S. Elkaffas, M. Breuer, et al.
Pathophysiological Factors Associated with Left Ventricular Perforation in Transcatheter Aortic Valve Implantation by Transfemoral Approach.
J Heart Valve Dis, 26 (2017), pp. 430-436
[28]
A.B. Willson, J.G. Webb, T.M. Labounty, S. Achenbach, R. Moss, M. Wheeler, et al.
3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: A multicenter retrospective analysis.
J Am Coll Cardiol, 59 (2012), pp. 1287-1294
[29]
G. Pontone, D. Andreini, A.L. Bartorelli, E. Bertella, S. Cortinovis, S. Mushtaq, et al.
Aortic annulus area assessment by multidetector computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation: A comparison with transthoracic and transesophageal echocardio.
Am Heart J, 164 (2012), pp. 576-584
[30]
N.C. Hansson, J. Leipsic, F. Pugliese, H.R. Andersen, A. Rossi, M. Simonato, et al.
Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.
J Cardiovasc Comput Tomogr, 12 (2018), pp. 290-297
[31]
M. Barbanti, S. Gulino, G. Costa, C. Tamburino.
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation.
Expert Rev Med Devices, 14 (2017), pp. 135-147
[32]
A. Hamdan, V. Guetta, R. Klempfner, E. Konen, E. Raanani, M. Glikson, et al.
Inverse Relationship between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation.
JACC Cardiovasc Interv, 8 (2015), pp. 1218-1228
[33]
K. Toutouzas, A. Synetos, D. Tousoulis, G. Latsios, S. Brili, A. Mastrokostopoulos, et al.
Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: The role of a new echocardiographic index.
Int J Cardiol, 172 (2014), pp. 601-603
asdasdasd
Opciones de artículo
Herramientas